Cost-effectiveness of telithromycin in the treatment of community-acquired pneumonia

被引：0
|
作者：
McGarry, LJ
Iskandar, R
Seal, B
Asche, C
Thompson, D
Weinstein, MC
机构：
[1] I3 Innovus Res Inc, Medford, MA USA
[2] Sanofi Aventis, Bridgewater, MA USA
[3] Univ Utah, Coll Pharm, Salt Lake City, UT 84112 USA
[4] Harvard Univ, Sch Publ Hlth, I3 INNOVUS Res Inc, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Boston, MA USA
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64332-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A6 / A6
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF COMMUNITY-ACQUIRED PNEUMONIA TREATMENT
    Zaytsev, A.
    Makarevich, A.
    Kondratyeva, T.
    VALUE IN HEALTH, 2014, 17 (07) : A596 - A596
  • [2] The Cost-Effectiveness of Corticosteroids for the Treatment of Community-Acquired Pneumonia
    Pliakos, Elina Eleftheria
    Andreatos, Nikolaos
    Tansarli, Giannoula S.
    Ziakas, Panayiotis D.
    Mylonakis, Eleftherios
    CHEST, 2019, 155 (04) : 787 - 794
  • [3] Telithromycin (Ketek) for treatment of community-acquired pneumonia
    Gleason, Patrick P.
    Shaughnessy, Allen F.
    AMERICAN FAMILY PHYSICIAN, 2007, 76 (12) : 1857 - 1858
  • [4] Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients
    Barker, J
    Patrick, H
    Badenhorst, C
    SOUTH AFRICAN MEDICAL JOURNAL, 1998, 88 (09): : 1048 - +
  • [5] Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia
    Dresser, LD
    Niederman, MS
    Paladino, JA
    CHEST, 2001, 119 (05) : 1439 - 1448
  • [6] Telithromycin in the treatment of community-acquired pneumonia: a pooled analysis
    Hagberg, L
    Carbon, C
    Van Rensburg, DJ
    Fogarty, C
    Dunbar, L
    Pullman, J
    RESPIRATORY MEDICINE, 2003, 97 (06) : 625 - 633
  • [7] COST-EFFECTIVENESS ANALYSIS OF DIFFERENT THERAPEUTIC REGIMENS IN TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN CHINA
    Sun, L.
    Dong, H.
    Sun, J.
    Wang, Y.
    Shi, W.
    Zhao, X.
    Wu, J.
    VALUE IN HEALTH, 2014, 17 (07) : A675 - A675
  • [8] Efficacy and safety of telithromycin in community-acquired pneumonia
    Van Rensburg, DJ
    Matthews, PA
    Leroy, B
    CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (07) : 397 - 400
  • [9] Clinical efficacy of telithromycin in the community-acquired pneumonia
    Gudiol, F
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2001, 19 : 24 - 27
  • [10] Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia
    Najib, MM
    Stein, GE
    Goss, TF
    PHARMACOTHERAPY, 2000, 20 (04): : 461 - 469
12345